top of page
Backgrounds.jpg
Statesman-Examiner Logo 2025 with Shadow.png

Loading...

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Dimensional U.S. Small Cap ETF (NY:DFAS)

75.64 +0.35 (+0.46%)
Streaming Delayed Price Updated: 3:22 PM EST, Jan 22, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Dimensional U.S. Small Cap ETF

B.Riley Stock Soars Nearly 40% - What’s Behind The Move? ↗
Via Stocktwits
News headline image
From Bitcoin Mining To AI: What’s Driving BitFarms’ Stock Jump Today? ↗
BitFarms agreed to sell its 70 MW site in Paraguay to a crypto infrastructure fund for $30 million as part of its plans to fully exit LatAm. 
Via Stocktwits
Topics Artificial Intelligence
News headline image
One Stop Systems Stock Rises After Hours On Selling Bressner To Focus On Higher-Growth Segments ↗
Hardware manufacturer OSS sold Bressner, which it acquired in October 2018, for $22.4 million to Hiper Euro GMBH on Tuesday. 
Via Stocktwits
Topics Artificial Intelligence
News headline image
Cassava Sciences Stock On Track For Worst Day In About 9 Months — What’s Driving Today’s Selloff? ↗
FDA placed a clinical hold on the proposed proof-of-concept clinical trial for Simufilam in tuberous sclerosis complex -related epilepsy earlier this week. 
Via Stocktwits
Why Did FuelCell Stock Rocket 35% Today? ↗
Via Stocktwits
FOSL Stock Plunges After Extending Exchange Offer For Its Senior Notes Due 2026 ↗
Via Stocktwits
TrueCar Shares Soar Following $227M Go-Private Deal ↗
Via Stocktwits
News headline image
Kezar Life Sciences Stock Hit With Downgrades And Price Target Cuts: Retail Keeps Hopes Alive ↗
Kezar announced on Thursday that it was unable to align with the FDA on a potential registrational clinical trial of Zetomipzomib in patients with relapsed and refractory autoimmune hepatitis. 
Via Stocktwits
Topics Workforce
News headline image
Cellectar Biosciences Stock Drops 17% On $5.8M Fundraise: Retail Awaits An ‘Impending’ Rally ↗
The company announced that it now intends to utilize the net proceeds for working capital and general corporate purposes, in addition to funding the early-stage trial of its CLR 125 compound in... 
Via Stocktwits
Topics Supply Chain
News headline image
Lyra Therapeutics To Conduct One More Trial For Chronic Rhinosinusitis Treatment Candidate ↗
The company stated that the design of the new trial will be based on the learnings from the previous trials, in addition to FDA feedback. 
Via Stocktwits
News headline image
Cash Cow Alert: 3 Small-Cap Stocks Making Big Profits ↗
Profitable small-cap stocks are still out there, even if finding profitability in small-cap stocks isn’t as easy as it once was. 
Via InvestorPlace
News headline image
3 Small-Cap Stocks to Juice Your Portfolio’s Long-Term Returns ↗
Owning too many small-cap stocks could be bad for your health. That doesn’t mean you shouldn’t own any. Here are three to buy now. 
Via InvestorPlace
News headline image
Small-Cap ETFs Enjoy Record Inflows Due To Optimistic Retail Investors: Is This The Decade Of 10% Annual Returns? ↗
Small-cap ETFs see record-breaking inflows, driven by retail investors. Bank of America predicts bullish outlook for 2024. 
Via Benzinga
Topics ETFs
News headline image
Top ETF Stories Of 2023 ↗
Investors have poured about $1 trillion into money market funds over the past year, lured by yields nearing 5% with very little risk. 
Via Talk Markets
Topics ETFs
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
bottom of page